Source comparison
MOTS-c Solution vs Other Research Peptides: Visual Comparison
MOTS-c Clear to faintly opalescent, colorless Cloudiness (aggregation), yellow tint (oxidation), particulates 1–5 mg/mL 28 days at 2–8°C Small 16-AA peptide with excellent solution stability when handled correctly. Visual clarity directly correlates with poten
This comparison does not assign a generated winner or score.
- MOTS-c
- Clear to faintly opalescent, colorless
- Cloudiness (aggregation), yellow tint (oxidation), particulates
- 1–5 mg/mL
- 28 days at 2–8°C
- Small 16-AA peptide with excellent solution stability when handled correctly. Visual clarity directly correlates with potency
- BPC-157
- Water-clear, colorless
- Cloudiness, sediment at bottom
- 0.5–2 mg/mL
- Stable pentadecapeptide. Rarely shows visible degradation within 28-day window if refrigerated
- Thymosin Beta-4
- Clear, may show slight blue fluorescence under UV
- Yellow discoloration (more common than other peptides)
- 2–5 mg/mL
- 21 days at 2–8°C
- Contains multiple oxidation-prone residues. Shorter shelf life and faster discoloration than MOTS-c
- CJC-1295
- Clear to slightly opalescent
- Gel formation (indicates polymerization), cloudiness
- 1–2 mg/mL
- Longer 30-AA sequence makes it more prone to aggregation if shaken during mixing
- Semaglutide
- Completely clear, slight viscosity increase vs water
- Cloudiness, increased viscosity (precipitation precursor)
- Larger peptide (31 AAs) with fatty acid modification. Higher molecular weight makes aggregation visually obvious sooner
- The MOTS-c peptide's relatively small size (1,675 Da molecular weight) makes it less prone to visible aggregation than longer research peptides like CJC-1295 or semaglutide. When you do see cloudiness in a MOTS-c solution, it represents a more severe degradation event than the same visual defect in a larger peptide. The aggregation threshold is higher, so crossing it means more extensive structural damage occurred.